v-2.jpg

Press Releases and Featured News

September 17, 2020 - Amytrx Therapeutics Emerges from Stealth to Develop Novel Therapies for Inflammatory Diseases with Lead Program AMTX-100 Currently in Clinical Development for Dermatologic Indications....read more

logo.png

Amytrx Therapeutics, Inc.

102 Woodmont Blvd | Suite 243 Nashville, TN 37205

400 Riverhill Business Park | Suite 410 Birmingham, AL 35242

Copyright © 2020  All Rights Reserved.